Joint single-nucleus RNA sequencing and single-nucleus ATAC sequencing of neuroblastoma cell lines
This study was undertaken to assess transcriptional and epigenetic heterogeneity a the  level of individual cells within neuroblastoma cell lines, and to compare cell lines with MYCN amplificaion to cell lines without MYCN amplification. Methods: We used 10X Genomics multiome sequencing technology to perform joint gene expression and ATAC profiling on thousands of nuclei isolated from the following human neuoblastoma cell lines: SHSY5Y, SK-N-AS, SK-N-SH, SK-N-DZ, Be-2c, and CHP134. Results: We found considerable gene expression and epigeneic heterogeneity both within and between neuroblastoma cell lines. Conclusion: Joint single-nucleus RNA sequencing and single-nucleus ATAC sequencing has demonsrated that neuroblastoma cell lines are heterogeneous, which may have implications for therapeutic strategies. Overall design: Use of 10X Genomics muliome sequencing technology (GEX + ATAC) to analyze single-cell transcriptomics and single-cell epigenetics of neuroblastoma cell lines.